EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische Studie

Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction

Giuseppe Tarantini, Benjamin Honton, Valeria Paradies, Gilles Lemesle, Gregoire Range iD, Matthieu Godin, Lionel Mangin, Thomas Cuisset, Juan M Ruiz-Nodar, Salvatore Brugaletta, Thibault Lhermusier, Christophe Piot und 14 weitere

New England Journal of Medicine · 27.11.2025 · 393 (21) · 2083-2094

DOI: 10.1056/nejmoa2508808 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift New England Journal of Medicine, erschienen am 27.11.2025. Verfasst von Giuseppe Tarantini und 25 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Cardiology Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Ita…. Hauptthemen laut MEDLINE: Aspirin, Dual Anti-Platelet Therapy, Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: MicroPort CRM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinDual Anti-Platelet TherapyMyocardial InfarctionPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsAgedFemaleHumansMaleMiddle AgedDrug Administration ScheduleDrug-Eluting StentsHemorrhageIncidenceKaplan-Meier EstimateProspective StudiesReceptors, Purinergic P2Y12Severity of Illness IndexStrokeThrombosisWithholding TreatmentTime Factors

Substanzen

AspirinP2RY12 protein, humanPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsReceptors, Purinergic P2Y12

Autor:innen und Institutionen

  • Interventional Cardiology Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua Medical School, Padua, Italy.
  • Department of Interventional Cardiology, Clinique Pasteur, Toulouse, France.
  • Maasstad Hospital, Rotterdam, the Netherlands.
  • Université de Lille, Institut Pasteur de Lille, INSERM Unité 1011, Lille, France.
  • Les Hôpitaux de Chartres, Chartres, France.
  • Clinique Saint-Hilaire, Rouen, France.

ORCID-Profile: Gregoire Range

Förderung

  • MicroPort CRM

Zitieren

APA

Tarantini, G., Honton, B., Paradies, V., Lemesle, G., Range, G., Godin, M., Mangin, L., Cuisset, T., Ruiz-Nodar, J. M., Brugaletta, S., Lhermusier, T., Piot, C., De Poli, F., Macia, J. C., Motreff, P., Madera-Cambero, M., Beygui, F., Riccini, P., Ranc, S., …, & TARGET-FIRST Investigators (2025). Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction. New England Journal of Medicine, 393(21), 2083-2094. https://doi.org/10.1056/nejmoa2508808

Vancouver

Tarantini G, Honton B, Paradies V, Lemesle G, Range G, Godin M, et al. Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction. New England Journal of Medicine. 2025;393(21):2083-2094. doi:10.1056/nejmoa2508808

BibTeX
@article{Tarantini2025,
  author = {Tarantini, Giuseppe and Honton, Benjamin and Paradies, Valeria and Lemesle, Gilles and Range, Gregoire and Godin, Matthieu and Mangin, Lionel and Cuisset, Thomas and Ruiz-Nodar, Juan M and Brugaletta, Salvatore and Lhermusier, Thibault and Piot, Christophe and De Poli, Fabien and Macia, Jean-Christophe and Motreff, Pascal and Madera-Cambero, Maribel and Beygui, Farzin and Riccini, Philippe and Ranc, Sylvain and Oreglia, Jacopo A and Vaquerizo, Beatriz and Poezevara, Yann and Bouchez, David and Smits, Pieter C and Cayla, Guillaume and TARGET-FIRST Investigators, TARGET-FIRST Investigators},
  title = {Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {21},
  pages = {2083--2094},
  doi = {10.1056/nejmoa2508808}
}
Kostenlos starten →